School of Medicine Latest News
UC Riverside mouse study suggests inflammation could play key role in progression to asthma
The California Wellness Foundation has awarded the School of Medicine a $450,000 grant
More than 7,100 students are eligible to graduate; Commencement events kick off on June 3 with the School of Medicine.
Bruce Doyle Varner, 84, UC regent, philanthropist, and prominent Riverside attorney, has died. A lifelong advocate for higher education, Varner was nominated to serve on the UC Board of Regents by Arnold Schwarzenegger in 2006, becoming one of the few Inland Empire-based regents in the board’s history. As a regent...
UC Riverside-led national survey of MS specialists finds nearly 10% had been redeployed to the front lines of COVID-19 patient care
Study by UC Riverside researchers will examine impacts of remote learning on families with children in grades K-12
The Regents of the University of California have given final approval for the construction of the School of Medicine’s new Education Building II at UC Riverside. The vote, which approved the final design, the full budget, and the California Environmental Quality Act, or CEQA, findings, took place during the Regents’...
Immunity generated by vaccination is better than immunity from an actual infection, says an expert
COVID-19 is far from beaten. Vaccines may not be the ultimate panacea to haul us out of the pandemic crisis. In the future, will outbreaks of SARS-CoV-2, the virus that causes COVID-19, arrive in waves every winter? Might COVID-19 never go away? Experts at the University of California, Riverside, weigh...
UC Riverside-led study examined the effects of the medication risperidone on brain metabolism in stuttering
UC Riverside-led mouse study stresses MS treatment should be started early
Dr. David Lo at the UC Riverside School of Medicine is an expert on vaccines
A UC Riverside-led study, funded by Merck, is set to find out
UC Riverside study examines molecular pathways that may instigate seizures in some multiple sclerosis patients
Phase 2 study investigates efficacy of the drug ecopipam developed by Emalex Biosciences Inc.
Host campus UC Riverside will be joined by UC Davis and UC Merced